Login to Your Account

A Difference of Opinion

Biotech Short Selling Up Slightly, But Not All Bad

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, December 12, 2011

Short sellers are generally considered blasphemers by biotech firms. And for good reason; short sellers borrow shares in order to sell them, which puts negative pressure on the stock. The only way shorts make money is if shares go down.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription